Therefore, we proposed that CD45-CD45 dimers may be formed between tumor cells shielded with CD45 and T cells that anchored CD45 in the immune synapse to inhibit ligated TCR signaling via its phosphatase activity though further strong evidence is needed to confirm this model (Fig. 7v). This evidence concerns the gene PTPRC and neoplasm.